[Does 5-ASA prevent development of colon cancer in ulcerative colitis?].
Several case control studies have demonstrated that in patients with ulcerative colitis, ingestion of 5-ASA is correlated with a reduced risk of developing colon cancer. A recent editorial in The American Journal of Gastroenterology concluded that "a 5-ASA tablet a day keeps the cancer away". However, the clinical studies in the meta-analysis upon which this conclusion is based are relatively small, and confounding could explain the observed correlation. A large study in which a chemoprotective effect of 5-ASA could not be found has been presented but has not yet been published. It would be advisable to wait for further documentation before 5-ASA is prescribed for chemo prevention of colonic cancer.